RxDoctor Payments Data

David Tuckman, MD

Hand Surgery · Great Neck, NYNPI 1194740977

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medartis Inc. accounts for 63.6% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $33,031 and has fallen 59.5% since, to $13,386 in 2025. Among hand surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$96,054in general payments, 2019–2025

Across 166 payments — averaging $578.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medartis Inc.$61K
  • Arthrex$32K
  • Stryker$547
  • Endo Pharmaceuticals Inc.$377
  • Bioventus LLC$355
  • Hitachi Healthcare Americas Corp.$316
  • plus $1K from 12 others

What the payments were for

  • Consulting fees$45,93048%
  • Speaking & faculty fees$36,81938%
  • Travel & lodging$7,5748%
  • Food & beverage$5,4146%
  • Entertainment$3160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$96,054 in reported general payments places this provider in the 95th percentile of 178 hand surgery providers in New York.

See all hand surgery providers in New York

Medicare billing

Part B allowed, 2024
$704,200
Medicare patients
1,326
Services billed
6,143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone48$347
Meloxicam26$64
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$53
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$42

Paid to pharmacies, not to this prescriber.

Other hand surgery in Great Neck

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →